Kaykof-Q Tablet is a multi-ingredient pharmaceutical formulation designed to provide comprehensive relief from symptoms associated with respiratory tract infections and allergic conditions. Each tablet contains Ambroxol 30 mg, a mucolytic agent that facilitates the breakdown and clearance of mucus, thereby improving airway patency. Cetirizine 5 mg, a second-generation antihistamine, offers effective relief from allergic manifestations such as rhinorrhea, sneezing, and nasal congestion by selectively inhibiting peripheral H1 receptors without causing significant sedation. Dextromethorphan Hydrobromide 15 mg acts as a centrally acting antitussive, suppressing the cough reflex to alleviate dry, non-productive cough. Guaifenesin 100 mg serves as an expectorant, promoting the loosening and expulsion of mucus from the respiratory tract, enhancing productive cough. Phenylephrine 10 mg, a selective alpha-1 adrenergic receptor agonist, provides symptomatic relief from nasal congestion by inducing vasoconstriction in nasal mucosa. The synergistic action of these components makes Kaykof-Q Tablet suitable for managing symptoms of common cold, bronchitis, allergic rhinitis, and other upper respiratory tract conditions. It is recommended to use this medication under medical supervision, especially in patients with hypertension, cardiovascular disorders, or hypersensitivity to any component. Kaykof-Q Tablet should be taken as directed to ensure optimal efficacy and safety.